Chronic disease management involves various clinical programs and services to help patients effectively manage medical conditions like diabetes, heart disease, asthma and hypertension on an ongoing basis. Chronic diseases are long-lasting health conditions that typically require ongoing management over many years. The programs focus on prevention of acute exacerbations and complications through continuous care, patient self-management education, and rehabilitation.
The increasing prevalence of chronic diseases due to unhealthy lifestyles and growing geriatric population has boosted the Chronic Disease Management Market Demand globally. Advanced solutions comprising population health management platforms, mobile disease management apps, remote patient monitoring devices and telehealth platforms help monitor patients regularly and provide timely interventions to prevent complications.
The Global Chronic Disease Management Market is estimated to be valued USD 6.49 Bn in 2025 and is expected to exhibit a CAGR of 13.6% over the forecast period 2025 to 2032.
Key Takeaways
Key players operating in the Chronic Disease Management are IBM Corporation, Cerner Corporation, Epocrates Inc.,
Growing demand - The rising incidence of chronic diseases is a major factor driving the demand for chronic disease management solutions. According to WHO, chronic diseases accounted for over 70% of all deaths worldwide in 2020. The growing geriatric population susceptible to multiple chronic conditions also boosts market growth.
Global expansion - Major chronic disease management solution providers are expanding their presence globally, especially in developing economies to tap the increased healthcare needs. For instance, Cerner established its offices in Australia, New Zealand, Middle East and Africa to cater to the rapidly evolving healthcare IT needs across different regions.
Market key trends
Remote Patient Monitoring is a key trend in chronic disease management. Advanced remote monitoring devices allow continuous tracking of vital signs like blood pressure, blood glucose and oxygen levels at home. This helps clinicians intervene timely and prevent health deteriorations. Growing investments by hospitals and payers in remote monitoring to reduce readmission rates and healthcare costs are promoting adoption of this trend.
Porter's Analysis
Threat of new entrants: Since it requires huge capital investments and long term research to enter this market, the threat from new entrants is low.
Bargaining power of buyers: Pharmaceutical companies and healthcare providers have significant bargaining power over the suppliers as they demand lower costs and better services.
Bargaining power of suppliers: Suppliers of raw materials, drugs, devices have moderate bargaining power due to the presence of many suppliers in the market.
Threat of new substitutes: Alternative treatment options are limited due to diseases being chronic in nature and substitutes are unlikely in the near future.
Competitive rivalry: The market is highly fragmented with the presence of global as well as regional players. This leads to high competitive pressure.
Geographical Regions
North America dominates the chronic disease management market currently, accounting for around 40% of the total market share in terms of value, followed by Europe and Asia Pacific. This is attributed to growing incidence of chronic diseases, supportive government initiatives and advanced healthcare infrastructure in the region.
Asia Pacific is expected to witness the highest growth during the forecast period due to rising healthcare expenditures, increasing healthcare awareness and rapidly improving medical services across developing nations such as India and China.
Get this Report in Japanese Language- 慢性疾患管理市場
Get this Report in Korean Language- 만성 질환 관리 시장
About Author-
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Known for her strong SEO background, she skillfully blends SEO strategies with insightful content. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
0 comment